ReviewFrontiers in pharmacology2024

Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target.

Yan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.